Business
Viveve(R) Announces Fourth Quarter Financial Highlights
Viveve(R) Announces Fourth Quarter Financial Highlights.
About this update from Viveve Medical, Inc.
[{"type":"text","content":"\nViveve(R) Announces Fourth Quarter Financial Highlights\n\nViveve(R) Announces Fourth Quarter Financial Highlights\n\n\n SUNNYVALE, CA--(Marketwired - January 07, 2016) - Viveve Medical, Inc. (\"Viveve\") (OTCQB: VIVMF), a company focused on women's health, today announced top-line financial results for the quarterly period ended December 31, 2015. The company began its global commercialization effort in the second half of 2015.\n Financial Result Highlights\n For the quarterly period ended December 31, 2015, total revenue from the sale of 21 Viveve Systems and 216 treatment tips is expected to be approximately $750,000 -- nearly a 30% increase over total revenue for the quarterly period ended September 30, 2015.\"We now have a total commercial installed base of 42 Viveve Systems, 33 of which were sold during the last two quarters of 2015. We anticipate an increase in this installed base as we continue to achieve regulatory clearances in additional countries,\" said Scott Durbin, Chief Financial Officer of Viveve.\"We believe that our safe, non-invasive and clinically proven treatment for vaginal laxity addresses a large clinical need, as evidenced by the continued growth in the demand for procedures. We believe that the distribution network we have established, with experienced distributors around the world, has begun to establish Viveve as a premier global brand focused on women's health,\" said Patricia Scheller, Chief Executive Officer of Viveve. Viveve cautions that its anticipated revenue results are preliminary based on the most current information available and are subject to completion of the consolidated financial statements for the fourth quarter of 2015. The company anticipates reporting its fourth quarter and annual 2015 financial results in March 2016. \n 2015 Company Achievements\n \n Expanded our commercialization team with the hiring of an experienced industry executive\n Announced a positive interim analysis from the VIVEVE I clinical study\n Research analyst coverage initiated by three firms\n Launched distribution coverage in 46 countries throughout the world\n Achieved regulatory approval in 20 of the 46 countries, which includes Japan under the physician import license pathway\n Completed $18 million in equity financing\n \n About ViveveViveve, Inc., the operating subsidiary of Viveve Medic...